Combination Antithrombotic Management for Non-ST Segment Elevation Acute Coronary Syndromes
Jayant Bagai1, Subhash Banerjee2, Emmanouil S Brilakis2
1Division of Cardiovascular Medicine, Tennessee Valley VA Healthcare System, Vanderbilt University Medical Center, Nashville, TN, USA.
Interventional Cardiology Clinics
|June 6, 2017
Summary
Patients with non-ST segment elevation acute coronary syndromes (NSTEACS) face high risk of thrombotic events. Combination antithrombotic therapy, including anticoagulants and antiplatelet agents, improves outcomes in these high-risk individuals.
Area of Science:
- Cardiology
- Thrombosis Research
- Pharmacology
Background:
- Non-ST segment elevation acute coronary syndromes (NSTEACS) present a significant risk for future thrombotic events.
- Effective management of NSTEACS is crucial for improving patient outcomes.
Purpose of the Study:
- To outline optimal antithrombotic management strategies for patients diagnosed with NSTEACS.
- To detail the selection of anticoagulants and antiplatelet agents based on planned treatment strategies.
Main Methods:
- Review of current guidelines and evidence for antithrombotic therapy in NSTEACS.
- Stratification of treatment recommendations based on early invasive versus early conservative management approaches.
Main Results:
- Combination therapy with anticoagulants and antiplatelet agents is recommended for high-risk NSTEACS patients.
- Specific anticoagulant choices (unfractionated heparin, bivalirudin, enoxaparin, fondaparinux) depend on the chosen management strategy.
- Aspirin is indicated for all NSTEACS patients, supplemented by a second antiplatelet agent.
Conclusions:
- Tailored antithrombotic management improves outcomes in NSTEACS.
- The choice of anticoagulant and the addition of a second antiplatelet agent are key components of NSTEACS care.
Related Concept Videos
01:28Acute Coronary Syndrome IV: Interprofessional Care
347
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
347
01:26Angina IV: Management
366
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
366
01:30Acute Coronary Syndrome I: Introduction
1.3K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.3K
01:26Acute Coronary Syndrome V: Nursing Management
419
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
419
01:27Coronary Artery Disease V: Interprofessional Care
346
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
346
01:26Atherosclerosis III: Management
520
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
520